Stockreport

Cancer Patients With Little Time Left Wait for Gilead’s New Drug [Bloomberg Business News]

JUNO THERAPEUTICS  (JUNO) 
Last juno therapeutics earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.junotherapeutics.com/investor-relations
PDF Two months after Gilead Sciences Inc.’s breakthrough treatment was approved in the U.S. to treat a deadly form of blood cancer, only a tiny handful of patien [Read more]